Public disclosures

INSM insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

2026-11-192026-11-20

45,700 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

2026-11-192026-11-20

55,400 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 41895 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $333,645.00

2,262 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 44157 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $1,253,183.64

8,539 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 52696 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $13,098,772.94

90,299 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 142995 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

2026-11-192026-11-20

45,700 shares/units

SEC 4Follow
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 97295 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

2026-11-192026-11-20

55,400 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement